These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26232393)

  • 41. Extended criteria donor lungs do not impact recipient outcomes in pediatric transplantation.
    Sommer W; Ius F; Müller C; Bobylev D; Kuehn C; Avsar M; Salman J; Siemeni T; Miha O J; Horke A; Haverich A; Tudorache I; Schwerk N; Warnecke G
    J Heart Lung Transplant; 2019 May; 38(5):560-569. PubMed ID: 30852096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of kidney transplantation from older living donors to older recipients.
    Gill J; Bunnapradist S; Danovitch GM; Gjertson D; Gill JS; Cecka M
    Am J Kidney Dis; 2008 Sep; 52(3):541-52. PubMed ID: 18653267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Pallardo Mateu LM; Beltran Catalan S; Puig Alcaraz N; Sancho Calabuig A; Gavela Martinez E; Avila Bernabeu A; Crespo Albiach J
    Transplant Proc; 2011; 43(6):2154-6. PubMed ID: 21839219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant.
    Stratta RJ; Rohr MS; Sundberg AK; Armstrong G; Hairston G; Hartmann E; Farney AC; Roskopf J; Iskandar SS; Adams PL
    Ann Surg; 2004 May; 239(5):688-95; discussion 695-7. PubMed ID: 15082973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of local versus imported expanded criteria donor kidneys: A single-center experience with 497 ECD kidney transplants.
    Khan MA; El-Hennawy H; Farney AC; Rogers J; Orlando G; Reeves-Daniel A; Palanisamy A; Gautreaux M; Iskandar S; Doares W; Kaczmorski S; Stratta RJ
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28612360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study.
    Summers DM; Johnson RJ; Hudson A; Collett D; Watson CJ; Bradley JA
    Lancet; 2013 Mar; 381(9868):727-34. PubMed ID: 23261146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kidney donor risk index is a good prognostic tool for graft outcomes in deceased donor kidney transplantation with short, cold ischemic time.
    Han M; Jeong JC; Koo TY; Jeon HJ; Kwon HY; Kim YJ; Ryu HJ; Ahn C; Yang J
    Clin Transplant; 2014 Mar; 28(3):337-44. PubMed ID: 24506770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Satisfactory outcomes with usage of extended criteria donor (ECD) kidneys in re-transplant recipients.
    Ortiz J; Parsikia A; Chang PN; Jamil MM; Campos S; Khanmoradi K; Zaki R; Rangaswami J
    Ann Transplant; 2013 Jun; 18():285-92. PubMed ID: 23792532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cold ischemic time is critical in outcomes of expanded criteria donor renal transplantation.
    Kim SM; Ahn S; Min SI; Park D; Park T; Min SK; Kim SJ; Ha J
    Clin Transplant; 2013; 27(1):132-9. PubMed ID: 23121153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The improvement in survival of expanded criteria donor kidneys with transplantation era.
    Carroll RP; Macgregor L; Walker RG
    Clin Transplant; 2008; 22(3):324-32. PubMed ID: 18190551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delayed graft function is correlated with graft loss in recipients of expanded-criteria rather than standard-criteria donor kidneys: a retrospective, multicenter, observation cohort study.
    Han F; Lin MZ; Zhou HL; Li H; Sun QP; Huang ZY; Hong LQ; Wang G; Cai RM; Sun QQ
    Chin Med J (Engl); 2020 Mar; 133(5):561-570. PubMed ID: 32053570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proposal of categorization of expanded criteria donors in renal transplantation.
    Koukoulaki M; Kyriakopoulos G; Nikolaidis C; Balaska A; Pistolas D; Drakopoulos S
    Transplant Proc; 2014 Nov; 46(9):3168-71. PubMed ID: 25420850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival after kidney transplantation does not differ with 50-59- or over 60-year-old expanded-criteria donors.
    Lai Q; Nudo F; Levi Sandri GB; Melandro F; Ferretti S; Grieco M; Garofalo M; Poli L; Pretagostini R; Berloco PB
    Transplant Proc; 2011 May; 43(4):1030-2. PubMed ID: 21620044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C1q-binding DSA and allograft outcomes in pediatric kidney transplant recipients.
    Hayde N; Solomon S; Caglar E; Ge J; Qama E; Colovai A
    Pediatr Transplant; 2021 Mar; 25(2):e13885. PubMed ID: 33131194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
    Wang CS; Gander J; Patzer RE; Greenbaum LA
    Am J Kidney Dis; 2018 Mar; 71(3):392-398. PubMed ID: 29277509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.